Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
276 studies found for:    "Glomerulonephritis"
Show Display Options
Rank Status Study
21 Unknown  ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
Condition: Glomerulonephritis, IGA
Interventions: Drug: prednisone + Inhibace/Cozaar;   Drug: Inhibace/Cozaar
22 Active, not recruiting
Has Results
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: belimumab
23 Completed BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
Conditions: Glomerulonephritis, Membranoproliferative;   Lupus Nephritis
Intervention: Drug: BG9588
24 Active, not recruiting Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Study)
Condition: IgA Glomerulonephritis
Interventions: Drug: methylprednisolone;   Drug: Placebo
25 Recruiting Efficacy and Safety of Losartan in Children With Ig A Nephropathy
Condition: Glomerulonephritis, IGA
Intervention: Drug: Losartan
26 Withdrawn Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Belimumab 10 mg;   Drug: Placebo
27 Recruiting Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Mycophenolate mofetil, low dose steroid;   Drug: Cyclosporin, low dose steroid
28 Completed Mycophenolate Mofetil in Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: mycophenolate mofetil orally 1000 mg twice a day (BID);   Drug: prednisone 0,5 mg/kg orally on alternate days;   Drug: intravenous (i.v.) methylprednisolone 1000 mg, total 9
29 Completed Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: Cyclophosphamide and steroids
30 Completed Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Conditions: Membranous Glomerulonephritis;   Lupus Membranous Nepropathy
Intervention: Drug: Sirolimus
31 Unknown  A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
Conditions: Glomerulonephritis, IGA;   Hypertension
Intervention: Drug: aliskiren
32 Completed A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Conditions: Glomerulonephritis;   IGA Nephropathy
Interventions: Drug: Valsartan;   Drug: Probucol;   Drug: Placebo
33 Active, not recruiting Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Conditions: Glomerulonephritis;   IgAN
Interventions: Drug: ATG-F;   Drug: Simulect
34 Unknown  Calcitriol in the Treatment of Immunoglobulin A Nephropathy
Conditions: Glomerulonephritis;   Autoimmune Diseases
Intervention: Drug: Calcitriol
35 Completed Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Conditions: Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: AMG 811
36 Recruiting ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Condition: SLE Glomerulonephritis Syndrome, WHO Class V
Intervention: Drug: Acthar gel
37 Completed Hospital Based Incidence of Group A Streptococcal Disease in Fiji
Condition: Streptococcus Group A
Intervention:
38 Terminated Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Conditions: Dense Deposit Disease;   Membranoproliferative Glomerulonephritis Type II;   C3 Glomerulonephritis
Intervention: Drug: CDX-1135
39 Unknown  Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Conditions: Dense Deposit Disease;   Membranoproliferative Glomerulonephritis
Intervention: Drug: Eculizumab
40 Completed Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
Conditions: Glomerulonephritis;   Nephrotic Syndrome
Intervention: Drug: Dexamethasone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.